VOLUME 58   1997   NUMBER 11

Brainstorms

468 Sex Therapy in Psychiatric Treatment Has a New Partner: Reproductive Hormones. Stephen M. Stahl
[PDF]

Original Articles

470 Comparative Prophylactic Efficacy of Lithium, Carbamazepine, and the Combination in Bipolar Disorder. Kirk D. Denicoff, Earlian E. Smith-Jackson, Elizabeth R. Disney, S. Omar Ali, Gabriele S. Leverich, and Robert M. Post
[Abstract] [PDF]

479 Olanzapine in Treatment-Refractory Schizophrenia: Results of an Open-Label Study. Joaquín Martín, Juan-Carlos Gómez, Enrique García-Bernardo, Manuel Cuesta, Enrique Alvarez, Manuel Gurpegui, and the Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia
[Abstract] [PDF]

484 A Double-Blind, Placebo-Controlled Study Comparing the Effects of Sertraline Versus Amitriptyline in the Treatment of Major Depression. R. Bruce Lydiard, Stephen M. Stahl, Marc Hertzman, and Wilma M. Harrison
[Abstract] [PDF]

492 Delusional Jealousy in Dementia. Shih-Jen Tsai, Jen-Ping Hwang, Chen-Hong Yang, and King-Ming Liu
[Abstract] [PDF]

Academic Highlights

501 The Pharmacologic Rationale for the Clinical Use of Antidepressants.
[PDF]

CME Activity 509

510 Determinants of Suicidal Ideation: The Role of Substance Use Disorders. Kenneth P. Pages, Joan E. Russo, Peter P. Roy-Byrne, Richard K. Ries, and Deborah S. Cowley
[Abstract] [PDF]

Letters to the Editor

495 Severe Atypical Symptoms Without Depression in SAD: Effects of Bright Light Therapy. Elena Ibatoullina, Nicole Praschak-Rieder, and Siegfried Kasper
[PDF]

495 Is Divalproex a CostEffective Alternative in the Acute and Prophylactic Treatment of Bipolar I Disorder? Roland M. Dardennes and Christian Even
[PDF]

Reply by Paul E. Keck, Jr., Jerry A. Bennett, and Sean P. Stanton [PDF]

496 Resolution of Fluoxetine-Induced Sexual Dysfunction With the 5-HT₃ Antagonist Granisetron. Erik B. Nelson, Paul E. Keck, Jr., and Susan L. McElroy
[PDF]

497 Olfactory Reference Syndrome Responds to Clomipramine But Not Fluoxetine: A Case Report. Roberto A. Dominguez and Alina Puig
[PDF]

498 Affective Illness and Epilepsy. Marcia Kaplan and Michael Privitera
[PDF]

Reply by Dietrich Blumer [PDF]

499 Blood Clozapine Levels Elevated by Fluvoxamine: Potential for Side Effects and Lower Clozapine Dosage. Scott C. Armstrong and James R. Stephans
[PDF]

Book Review 500

Information for Authors

see July 1997, pages 287_288